Humble Group reported a modest organic increase in preliminary net sales for the second quarter, with revenues rising 1% to SEK 2.0 billion. The fast-moving consumer goods company said preliminary EBITA for the quarter was SEK 120 million, effectively flat compared with the prior period.
Despite stable EBITA, the company recorded non-cash impairments totaling SEK 600 million that pushed operating profit into a deep loss for the quarter. The impairments were split between two headline items: a SEK 280 million goodwill write-down associated with the divestment of Fancystage, and a SEK 320 million impairment tied to a reassessment of goodwill and intangible assets in the Sustainable Care business area.
The divestment of Fancystage produced the SEK 280 million non-cash goodwill impairment. According to the company, disposing of the subsidiary will likely reduce the group's annual sales, but the transaction is expected to be accretive to annual operating profit.
Separately, Humble Group said it booked a SEK 320 million non-cash impairment following an updated valuation of goodwill and intangible assets within its Sustainable Care segment. The company did not disclose additional valuation details in the preliminary update.
Management reiterated that the company continues to run a strategic review and is evaluating additional divestments and acquisitions. The review remains ongoing, and the company signaled that further portfolio moves are possible as it seeks to reshape its asset base.
For the quarter overall, the preliminary results portray a business with modest organic top-line momentum and stable operating performance at the EBITA level, offset by one-off accounting charges that materially altered reported operating profit. The company framed the Fancystage sale as a step that should bolster operating profitability on an annual basis despite the near-term reduction in sales.
Investors and market participants will likely view the numbers through the lens of portfolio simplification: revenue growth was limited but recurring operating earnings pre-impairment were unchanged, while the impairments reflect balance-sheet adjustments tied to recent disposals and an updated valuation in one business area. The group has indicated it remains active on both the disposal and acquisition fronts as part of its strategic review.
Key context
- Preliminary Q2 net sales: SEK 2.0 billion, up 1% organic.
- Preliminary Q2 EBITA: SEK 120 million, flat year-on-year.
- Total non-cash impairments in the quarter: SEK 600 million, leading to a sharply negative operating profit.